Daré Bioscience, Inc.

NasdaqCM:DARE Stock Report

Market Cap: US$48.8m

Daré Bioscience Management

Management criteria checks 3/4

Daré Bioscience's CEO is Sabrina Johnson, appointed in May 2015, has a tenure of 8.92 years. total yearly compensation is $1.67M, comprised of 27.8% salary and 72.2% bonuses, including company stock and options. directly owns 0.96% of the company’s shares, worth $466.51K. The average tenure of the management team and the board of directors is 5.8 years and 6 years respectively.

Key information

Sabrina Johnson

Chief executive officer

US$1.7m

Total compensation

CEO salary percentage27.8%
CEO tenure8.9yrs
CEO ownership1.0%
Management average tenure5.8yrs
Board average tenure6yrs

Recent management updates

Recent updates

We're A Little Worried About Daré Bioscience's (NASDAQ:DARE) Cash Burn Rate

Nov 07
We're A Little Worried About Daré Bioscience's (NASDAQ:DARE) Cash Burn Rate

We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully

Jul 21
We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully

Is Daré Bioscience (NASDAQ:DARE) In A Good Position To Invest In Growth?

Mar 12
Is Daré Bioscience (NASDAQ:DARE) In A Good Position To Invest In Growth?

Daré rises on positive data from early-to-mid-stage trial of intravaginal ring to treat menopause symptoms

Oct 17

Daré Bioscience rises as company submits application to begin trial of non-hormonal contraceptive

Oct 10

Dare Bioscience reports positive progress for cream for female sexual arousal disorder

Aug 29

Daré Bioscience signs agreement with Organon for bacterial vaginosis therapy

Jun 30

Will Daré Bioscience (NASDAQ:DARE) Spend Its Cash Wisely?

Apr 02
Will Daré Bioscience (NASDAQ:DARE) Spend Its Cash Wisely?

Diving Back Into Daré Bioscience Again

Jan 07

We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully

Nov 26
We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully

Daré Bioscience's DARE-BV1 shows positive action in late-stage bacterial vaginosis study

Apr 26

Diving Into Daré Bioscience

Jan 31

Why Daré Bioscience, Inc. (NASDAQ:DARE) Could Be Worth Watching

Dec 22
Why Daré Bioscience, Inc. (NASDAQ:DARE) Could Be Worth Watching

Dare Bioscience EPS misses by $0.06

Nov 12

CEO Compensation Analysis

How has Sabrina Johnson's remuneration changed compared to Daré Bioscience's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$30m

Sep 30 2023n/an/a

-US$41m

Jun 30 2023n/an/a

-US$40m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$2mUS$466k

-US$31m

Sep 30 2022n/an/a

-US$25m

Jun 30 2022n/an/a

-US$30m

Mar 31 2022n/an/a

-US$40m

Dec 31 2021US$2mUS$405k

-US$39m

Sep 30 2021n/an/a

-US$38m

Jun 30 2021n/an/a

-US$33m

Mar 31 2021n/an/a

-US$30m

Dec 31 2020US$835kUS$368k

-US$27m

Sep 30 2020n/an/a

-US$23m

Jun 30 2020n/an/a

-US$19m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$629kUS$335k

-US$15m

Sep 30 2019n/an/a

-US$14m

Jun 30 2019n/an/a

-US$13m

Mar 31 2019n/an/a

-US$12m

Dec 31 2018US$618kUS$325k

-US$17m

Sep 30 2018n/an/a

-US$23m

Jun 30 2018n/an/a

-US$22m

Mar 31 2018n/an/a

-US$19m

Dec 31 2017US$291kUS$144k

-US$12m

Compensation vs Market: Sabrina's total compensation ($USD1.67M) is above average for companies of similar size in the US market ($USD674.64K).

Compensation vs Earnings: Sabrina's compensation has been consistent with company performance over the past year.

CEO

Sabrina Johnson (56 yo)

8.9yrs

Tenure

US$1,673,479

Compensation

Ms. Sabrina Martucci Johnson serves as Director at BIOCOM, Inc. since February 2021. Ms. Johnson Founded Daré Bioscience since 2015 and serves as its Chief Executive Officer and President and is its Princi...

Leadership Team

NamePositionTenureCompensationOwnership
Sabrina Johnson
CEO, President8.9yrsUS$1.67m0.96%
$ 466.5k
Lisa Walters-Hoffert
Executive Officerless than a yearUS$779.44k0.44%
$ 215.1k
Mark Walters
Vice President of Operations9.3yrsno datano data
MarDee Haring-Layton
Chief Accounting Officer2yrsno datano data
David Friend
Chief Scientific Officer5.8yrsno datano data

5.8yrs

Average Tenure

60yo

Average Age

Experienced Management: DARE's management team is seasoned and experienced (5.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Sabrina Johnson
CEO, President6.8yrsUS$1.67m0.96%
$ 466.5k
William Rastetter
Independent Chairman of the Board10.3yrsUS$127.42k0.010%
$ 5.0k
Robert Langer
Member of Scientific Advisory Board5.1yrsno datano data
Susan Kelley
Independent Director9.5yrsUS$92.42k0%
$ 0
Cheryl Blanchard
Independent Director4.4yrsUS$87.92k0%
$ 0
Robin Steele
Independent Director6.8yrsUS$95.42k0.24%
$ 119.4k
Jessica Grossman
Independent Director6yrsUS$93.92k0%
$ 0
Gregory Matz
Independent Director5.6yrsUS$106.42k0.00050%
$ 243.9
Sophia Ononye-Onyia
Independent Director3yrsUS$87.45k0%
$ 0

6.0yrs

Average Tenure

63yo

Average Age

Experienced Board: DARE's board of directors are considered experienced (6 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.